<DOC>
	<DOCNO>NCT02472457</DOCNO>
	<brief_summary>Crohn disease ( CD ) idiopathic , chronic , relapse remit inflammatory condition gastrointestinal tract high risk complication need surgical intervention , particularly child . Immunomodulators biologic therapy effective induce maintain remission pediatric CD , yet prove strategy reduce exposure medication sustain remission achieve . Diet proven impact disease activity CD may allow sustain drug-free remission . The primary objective study determine whether pediatric CD patient long-standing remission remain remission longer stop medication follow Crohn 's Disease Exclusion Diet ( CDED ) . The hypothesis subject CDED longer time-to-relapse oppose unrestricted diet .</brief_summary>
	<brief_title>Crohn Disease Exclusion Diet After Single Medication De-escalation</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Patients diagnosis Crohn Disease use Revised Porto criterion withdraw biologic immunomodulator monotherapy part clinical care . Normal Growth Velocity , Tanner 5 Steroidfree Remission ( Pediatric Crohn Disease Activity Index Score &lt; 10 without height component ) least 12 month prior enrollment Colonoscopy precede 3 month complete mucosal heal aphthous ulceration locate one segment Stool calprotectin &lt; 250Âµg/g precede 3 month Parental/guardian permission ( informed consent ) , appropriate , child assent . Discontinuation biologic immunomodulator therapy subject without approval primary gastroenterologist . Those subject judgment investigative team unable complete study endpoint .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>